| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/24/2011 | EP2358715A1 3-(3-pyrimidin-2-yl-benzyl)-[1,2,4]triazolo[4,3-b]pyrimidine derivatives |
| 08/24/2011 | EP2358710A1 Akt and p70 s6 kinase inhibitors |
| 08/24/2011 | EP2358703A1 Tetrasubstituted pyridazines hedgehog pathway antagonists |
| 08/24/2011 | EP2358702A2 Piperidine compounds, pharmaceutical composition comprising the same and its use |
| 08/24/2011 | EP2358697A1 Isoindoline compounds for use in the treatment of cancer |
| 08/24/2011 | EP2358693A2 Preparation of docetaxel |
| 08/24/2011 | EP2358689A1 Benzothiazole derivatives as anticancer agents |
| 08/24/2011 | EP2358370A2 Treatment of proteinopathies using a farnesyl transferase inhibitor |
| 08/24/2011 | EP2358203A1 Platinum acridine anti-cancer compounds and methods thereof |
| 08/24/2011 | EP2152702B1 Amino-thiazolyl- pyrimidine derivatives and their use for the treatment of cancer |
| 08/24/2011 | EP1951687B1 N-hydroxyamide derivatives and use thereof |
| 08/24/2011 | EP1856155B1 Monoclonal antibodies and immunodetection assay specific for the chemotactic epitope of the urokinase-type plasminogen activator receptor |
| 08/24/2011 | EP1856095B1 Quinazoline derivatives as tyrosine kinase inhibitors |
| 08/24/2011 | EP1773451B1 Use of 7-t-butoxyiminomethylcamptothecin for treating uterine neoplasms |
| 08/24/2011 | EP1684736B1 Dna damage repair inhibitors for treatment of cancer |
| 08/24/2011 | EP1594895B1 Growth factor complexes and modulation of cell migration and growth |
| 08/24/2011 | EP1558616B2 Meso-substituted porphyrins |
| 08/24/2011 | EP1553948B1 Combination of imatnib and a histone deacetylase inhibitor for the treatment of leukemia |
| 08/24/2011 | EP1536006B1 Cancer antigens and utilization thereof |
| 08/24/2011 | EP1531843B1 Method for treating cervical cancer |
| 08/24/2011 | EP1499729B1 Derivatives of the nf-kappab inducing enzyme, their preparation and use |
| 08/24/2011 | EP1485353B1 New inhibitors of histone deacetylase |
| 08/24/2011 | EP1480962B1 5-phenylthiazole derivatives and use as pi3 kinase inhibitors |
| 08/24/2011 | EP1333833B1 Novel trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compound for the treatment of CSBP/p38 kinase mediated diseases |
| 08/24/2011 | EP1259544B1 Heterologous polypeptide of the tnf family |
| 08/24/2011 | EP0981618B2 Anti-apo-2 antibody |
| 08/24/2011 | EP0754059B2 Methods and compositions useful for inhibition of angiogenesis |
| 08/24/2011 | CN102165061A Modulation of TOLL-like receptor 9 expression by antisense oligonucleotides |
| 08/24/2011 | CN102164962A Anti-GD2 antibodies and methods and uses related thereto |
| 08/24/2011 | CN102164941A Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the C-ring |
| 08/24/2011 | CN102164920A Alkylthiazol carbamate derivatives, preparation thereof and therapeutic use thereof as FAAH enzyme inhibitor |
| 08/24/2011 | CN102164917A Compounds which selectively modulate the CB2 receptor |
| 08/24/2011 | CN102164916A Compounds which selectively modulate the CB2 receptor |
| 08/24/2011 | CN102164913A Crystalline forms of a 3-pyrrole substituted 2-indolinone malate salt |
| 08/24/2011 | CN102164904A 6-substituted isoflavonoid compounds and uses thereof |
| 08/24/2011 | CN102164902A 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase |
| 08/24/2011 | CN102164888A Deacetylase inhibitors and uses thereof |
| 08/24/2011 | CN102164887A Halogenated analogues of anti-fibrotic agents |
| 08/24/2011 | CN102164638A Use of histone deacetylase inhibitors for the care of philadelphia-negative myeloproliferative syndromes |
| 08/24/2011 | CN102164617A Compositions and methods for achieving sustained therapeutic drug concentrations in a subject |
| 08/24/2011 | CN102164595A Nutritional support of the immune system during anti-cancer treatment |
| 08/24/2011 | CN102161982A Monoclonal antibodies (McAb) against human CXCR3 molecules and application thereof |
| 08/24/2011 | CN102161710A Method for preparing tremellan with low molecular weight and novel medicinal application thereof |
| 08/24/2011 | CN102161680A Phosphamide ester camptothecin derivative as well as preparation method, pharmaceutical composition and usage thereof |
| 08/24/2011 | CN102161679A Compositions and methods for treating cancer |
| 08/24/2011 | CN102161655A Apigenin derivatives and preparation method and applications thereof |
| 08/24/2011 | CN102161649A Polyphenol type derivatives extracted from mulberry leaves and preparation method and applications thereof |
| 08/24/2011 | CN102161648A Preparation method and applications of isoflavone type compounds with selective estrogen receptor modulating activity |
| 08/24/2011 | CN102161647A Preparation method and applications of isoflavone type multidrug resistance reversal agent of cancer cell |
| 08/24/2011 | CN102161643A Heterocyclic carboxylic acid derivative and application as endothelin receptor antagonist thereof |
| 08/24/2011 | CN102160895A Application of PITPNM3 gene in preparing medicine for inhibiting breast cancer invasion and transfer |
| 08/24/2011 | CN102160868A Application of astragaloside IV in preparing liver cancer resisting medicines |
| 08/24/2011 | CN102160867A Application of astragaloside II in preparing anti-cancer medicines |
| 08/24/2011 | CN102160864A Improved cancer treatment with temozolomide |
| 08/24/2011 | CN102160863A Purification preparation method of isoalantolactone and application of isoalantolactone in preparation of anti-tumor drugs |
| 08/24/2011 | CN101874873B Traditional Chinese medicine for treating tumors |
| 08/24/2011 | CN101829164B Biological preparation method of Hypericum perforatum L extractive |
| 08/24/2011 | CN101773532B Carpesium abrotanoides total terpene lactones extract |
| 08/24/2011 | CN101766619B Pharmaceutical composition for malignancy treatment and application thereof |
| 08/24/2011 | CN101744832B Chinese traditional medicine preparation for reversing multiple medicine resistance of tumor cells and preparation method thereof |
| 08/24/2011 | CN101683380B Method for preparing irrigating solution with anti-tumor function |
| 08/24/2011 | CN101632756B Traditional Chinese medicine for treating malignant tumours and preparation method thereof |
| 08/24/2011 | CN101628114B Broad spectrum anti-tumor composite vaccine |
| 08/24/2011 | CN101550191B Malignant melanoma T cell nano antibody, coding sequence and application thereof |
| 08/24/2011 | CN101549042B Method for extracting amino acid from potatoes and application of extract thereof |
| 08/24/2011 | CN101485799B Paste capable of dispelling pain and eliminating cancer |
| 08/24/2011 | CN101439055B Use of aqueous extract of Trametes robiniophila Murr. in preparing medicament |
| 08/24/2011 | CN101375954B Medicament composition, preparation method thereof and use |
| 08/24/2011 | CN101229167B Method of preparing sodium levofolinate and applications thereof on preparing tumour-curing medicines |
| 08/24/2011 | CN101102776B Antitumor agent |
| 08/23/2011 | US8003805 N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 08/23/2011 | US8003791 Boronic ester and acid compounds, synthesis and uses |
| 08/23/2011 | US8003786 Dihydropteridinone compounds |
| 08/23/2011 | US8003772 Chimeric PUFA polyketide synthase systems and uses thereof |
| 08/23/2011 | US8003763 for in vitro diagnostics/antitumor agents; gene overexpression of cell surface proteins; bind Cripto and block the interaction between Cripto and activin-like kinase (ALK) 4 |
| 08/23/2011 | US8003758 BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells |
| 08/23/2011 | US8003651 Pyrimidyl cyclopentanes as AKT protein kinase inhibitors |
| 08/23/2011 | US8003643 Inhibitors of Akt activity |
| 08/23/2011 | US8003625 Phosphoramidate alkylator prodrugs |
| 08/23/2011 | US8003347 Nucleic acids encoding ChemerinR ligands |
| 08/23/2011 | US8003315 TAOJIKs as modifiers of the beta-catenin pathway and methods of use |
| 08/23/2011 | US8003109 Pharmaceutical compositions containing the long pentraxin PTX3 |
| 08/23/2011 | US8003089 Y shape branched hydrophilic polymer derivatives, their preparation methods, conjugates of the derivatives and drug molecules, and pharmaceutical compositions comprising the conjugates |
| 08/23/2011 | CA2656535C Alkyne-substituted pyridone compounds and methods of use |
| 08/23/2011 | CA2562756C Methods for controlling angiogenesis and cell proliferation using a desulphatohirudin |
| 08/23/2011 | CA2485494C Anti-tumour polycyclic carboxamides |
| 08/23/2011 | CA2483162C Use of 3-substituted amino-1h-indole-2-carboxylic acid and 3-substituted amino benzo[b]thiophene-2-carboxylic acid derivatives as il-4 inhibitors |
| 08/23/2011 | CA2478186C Fluorinated 4-azasteroid derivatives as androgen receptor modulators |
| 08/23/2011 | CA2462276C 3,4-methylenedioxy-substituted chalcones as therapeutic agents |
| 08/23/2011 | CA2451006C 1,2,4-trioxolane antimalarials |
| 08/23/2011 | CA2442159C Treatment using neublastin polypeptides |
| 08/23/2011 | CA2410595C Use of aloe-emodin in the treatment of neuroectodermal tumors |
| 08/23/2011 | CA2377209C Therapeutic peptide-based constructs |
| 08/23/2011 | CA2335488C Conformationally constrained backbone cyclized somatostatin analogs |
| 08/23/2011 | CA2270176C Methylated, smd homologous peptides, reactive with the antibodies from sera of living beings affected with systemic lupus erythematosus |
| 08/23/2011 | CA2203888C Al-1 neurotrophic factor, a ligand for an eph-related tyrosine kinase receptor |
| 08/18/2011 | WO2011100769A2 Kinase modulators for the treatment of cancer |
| 08/18/2011 | WO2011100685A2 Methods of generating hyper inos expressing cells and uses thereof |
| 08/18/2011 | WO2011100642A2 Method for treating hematological cancers |
| 08/18/2011 | WO2011100502A1 7-aminofuropyridine derivatives |